Results 11 to 20 of about 78,294 (297)
The multidisciplinary approach to eosinophilia [PDF]
Frontiers in Oncology, 2023 Eosinophilic granulocytes are normally present in low numbers in the bloodstream. Patients with an increased number of eosinophilic granulocytes in the differential count (eosinophilia) are common and can pose a clinical challenge because conditions with
Gunhild Nynke Thomsen +20 more
doaj +2 more sources
Drug-Induced Eosinophilia [PDF]
Безопасность и риск фармакотерапии, 2019 EEosinophilia can be caused by various reasons, including taking certain medications, in which case it is called drug-induced. The relevance of drug-induced eosinophilia issue is due to the serious consequences associated with this condition, in ...
O. D. Ostroumova +2 more
doaj +2 more sources
The diagnostic difficulties of eosinophilia in clinical practice - case series [PDF]
Journal of Education, Health and Sport, 2019 Introduction: Eosinophilia, defined as elevated level of eosinophils in peripheral blood above 5 x 109/L, is the hematological disorder, which may occur in multiple conditions, such as allergies, gastrointestinal, autoimmune diseases, parasite, fungal ...
Agnieszka Szymczyk +7 more
doaj +4 more sources
Peripheral blood eosinophilia in dogs: Prevalence and associated diseases
Veterinary Medicine and Science, 2022 Background Canine eosinophilia has not been evaluated over the last two decades. As in human local differences, changes in the prevalence and associated diseases over time can be expected.
Abigail Guija‐de‐Arespacochaga +3 more
doaj +2 more sources
Unraveling the diagnostic puzzle of eosinophilia in children [PDF]
Global PediatricsEosinophilia is characterized by an increased eosinophil count in peripheral blood, and presents diagnostic challenges in children. Clinical manifestations can range from mild to severe, necessitating a nuanced understanding of its causes and management ...
Elena Chiappini
doaj +2 more sources
Natalizumab induced blood eosinophilia: A retrospective pharmacovigilance cohort study and review of the literature. [PDF]
, 2021 OBJECTIVE To describe frequency of natalizumab related eosinophilia and clinical symptoms of eosinophilic disease in our monocentric cohort. METHODS Comparison of clinical characteristics of 115 natalizumab treated and 116 untreated RRMS ...
Friedli, C. +11 more
core +2 more sources
Clinical Infection in Practice, 2023 Background: Previous research has shown the potential benefit of eosinophilia in respiratory viral infections, which could suggest a milder clinical course and outcome for those with COVID-19 infection.
Mark Reed +2 more
doaj +1 more source
Eosinophilia during natalizumab treatment: Incidence, risk factors and temporal patterns
, 2021 Eosinophilia is common during natalizumab treatment for multiple sclerosis but risk factors are unknown. We aimed to identify demographic, clinical and laboratory characteristics predicting eosinophilia. Sustained eosinophilia occurred in 16.8%.
Sheikh, Saima +7 more
core +1 more source
Eosinophilia and risk of incident end stage kidney disease
BMC Nephrology, 2020 Background Eosinophils in kidney disease are poorly understood and are often incidental findings on kidney biopsy. Eosinophilia in blood and renal biopsy tissue is associated with a host of immune and non-immune kidney diseases.
Anam Tariq +7 more
doaj +1 more source
Evidence of helminthic infestation and efficacy of anthelminthic treatment in children investigated for eosinophilia [PDF]
Vojnosanitetski PregledBackground/Aim. The cause of eosinophilia often remains unelucidated. The aim of the study was to analyze causes and treatment approaches in children with eosinophilia in pediatric tertiary care hospital. Methods.
Rodić Predrag +6 more
doaj +1 more source